Work

Efficacy of ramucirumab and docetaxel given either before or after immune checkpoint inhibitors in patients with lung cancers.

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.15_suppl.9078

Authors: Michael Offin, Chongrui Xu, Harsh Jain, Alex Makhnin, Sara A. Hayes, Andrew J. Plodkowski, Darragh Halpenny, Charles M. Rudin, Mark G. Kris, Alexander E. Drilon, Bob T. Li, Paul K. Paik

Institutions: Memorial Sloan Kettering Cancer Center, Guangdong General Hospital, Guangdong Academy of Medical Sciences

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2963694464

Cites:

Cited by: 6

Related to: 10